Guardant Health Inc (NASDAQ:GH) price on current trading day, rose 7.04% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $43.19.
A look at the stock’s price movement, the close in the last trading session was $40.35. Turning to its 52-week performance, $50.89 and $15.81 were the 52-week high and 52-week low respectively. Overall, GH moved -8.07% over the past month.
Guardant Health Inc’s market cap currently stands at around $5.33 billion, with investors looking forward to this quarter’s earnings report slated for in March.
Analysts have a consensus estimate of 190.03M for the company’s revenue for the quarter, with a low and high estimate of 186M and 199M respectively. The average forecast suggests up to a 12.78% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 854.41M, representing a 15.61% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that GH is a 50% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
13 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 13 recommend GH as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
GH’s current price about -6.05% and 6.82% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 48.04, while 7-day volatility ratio is 9.10% and 5.93% in the 30-day chart. Further, Guardant Health Inc (GH) has a beta value of 1.51, and an average true range (ATR) of 2.92. Analysts have given the company’s stock an average 52-week price target of $40, forecast between a low of $36 and high of $125. Looking at the price targets, the low is 16.65% off current price level while to achieve the yearly target high, price needs to move -189.42%. Nonetheless, investors will most likely welcome a 7.39% jump to $40 which is the analysts’ median price.
If we refocus on Guardant Health Inc (NASDAQ:GH), historical trading data shows that trading volumes averaged 2.12 million over the past 3 months. The company’s latest data on shares outstanding shows there are 123.99 million shares.
The 4.37% of Guardant Health Inc’s shares are in the hands of company insiders while institutional holders own 96.31% of the company’s shares. Current price change has pushed the stock 41.37% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the GH stock continues to rise going into the next quarter.
